Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Mylan N.V. Tranexamic Acid and Amiodarone HCl injections - recalled due to Vials potentially packaged in incorrect cartons, United States
3 years ago •source www.fda.gov
Recall notice
United States
Company name: Mylan N.V.Brand name: Mylan
Product recalled: Tranexamic Acid and Amiodarone HCl injections
Reason of the recall: Vials potentially packaged in incorrect cartons
FDA Recall date: August 31, 2020
Recall details: Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP 450 mg/9 mL, packaged in cartons of 10 single-dose 9 mL vials and Tranexamic Acid Injection, USP 1000 mg/10 mL, packaged in cartons of 10 single-dose 10 mL vials.
These batches are being recalled due to the potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP. The individual vials contained within the cartons are accurately labeled as Amiodarone HCl Injection, USP or Tranexamic Acid Injection, USP. Both of these medications are administered in a hospital setting only by trained healthcare professionals. To date, Mylan has not received any reports of adverse events related to this recall.
Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP are used to treat different conditions. If Tranexamic acid is administered to a patient in place of Amiodarone or vice versa, it could present a risk to patient safety. If Amiodarone HCl Injection is inadvertently administered it could result in low blood pressure and irregular heartbeat, including lower than expected heart rate, which could have immediate life-threatening effects on cardiac function. If treatment with Amiodarone HCl Injection, when needed, is delayed this could result in continued irregular heartbeat and potential life-threatening effects on cardiac function.
If Tranexamic Acid Injection is inadvertently administered it could result in adverse events, including blood clotting, seizures, hypersensitivity reactions, visual disturbances, and dizziness. If treatment with Tranexamic Acid Injection, when needed, is delayed this could result in limited to serious and life-threatening bleeding events. Amiodarone HCl Injection, USP is an antiarrhythmic agent indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients’ refractory to other therapy. Tranexamic acid injection is indicated in patients with hemophilia for short term use to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
These batches were distributed nationwide in the USA to wholesalers and hospital/clinical pharmacies between April 2020 and July 2020. The recalled batch information is as follows:
NDC #: 67457-153-09
Material Description: Amiodarone HCl Injection, USP
Strength: 450 mg/9 mL
Carton Size: 10 x 9 mL single-dose vials
Lot No.: 191207 / 191221 / 191223 / 200120
Expiry: Nov. 2021 / Nov. 2021 / Nov. 2021 / Nov. 2021
NDC #: 67457-197-10
Material Description: Tranexamic Acid Injection, USP
Strength: 1000 mg/10 mL
Carton Size: 10 x 10 mL single-dose vials
Lot No.: 191207 / 191221 / 191223 / 200120
Expiry: Nov. 2021 / Nov. 2021 / Nov. 2021 / Nov. 2021
Mylan is notifying its wholesalers and hospital/clinic pharmacies by letter and is arranging for return of recalled products to Stericycle. Wholesalers and hospital/clinic pharmacies that have product which is being recalled should stop use/further distribution or dispensing.
Check the full recall details on www.fda.gov
Source: FDA
Recent Interesting Reports
Tech 1 Scam, East Patchogue, NY, USA
4 weeks ago •reported by user-trjrk773
I received a butane lighter; a cheap
ADM Animal Nutrition Chicken, Swine and Rabbit Feed Products Update - recalled due elevated levels of minerals, USA
2 weeks ago •source www.fda.gov
Recall notice
Elevated levels of sodium can cause increased water consumption, reduced feed efficiency, egg production, and growth rate and can be fatal in chickens. Elevated levels of calcium and/or phosphorus can cause reduced feed intake and feed conversion in swine, and elevated levels of magnesium and sodium can cause loose stools, reduced growth rate, and weakness in rabbits.
In case your animals experience harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance.
Company name: ADM Animal Nutrition
Brand name: Pen Pals, MaxLean, ShowTec, MoorMan's
Product recalled: Chicken, Swine and Rabbit Feed Products
Reason of the recall: Specific lots may contain elevated levels of magnesium, sodium, calcium and/or phosphorus
FDA Recall date: April 11, 2024
Source: www.fda.gov
I am reporting a ring I got in the mail today but never ordered., Lewisville, TX, USA
3 weeks ago •reported by user-qzfj8618
I am reporting unordered package, Michigan, USA
1 week ago •reported by user-cghc2873
Heather Fottys
646 S Walcott Ave
Chicago IL. 60609
Online scam, AIBIYIN CO., LIMIDET
3 weeks ago •reported by user-fqfn3189
Invoice number 2403181302*****
transaction code
2TK99707LJ36*****
Gummies - Fraudulent order, 192-01 Northern Boulevard, Flushing, NY, USA
2 weeks ago •reported by user-qvmpn268
Crap I didn’t order, Broadview Heights, Ohio, USA
3 weeks ago •reported by user-dtfbw861
AuroMedics Pharma Methocarbamol Injection - recalled due to Particulate Matter presence, USA
4 weeks ago •source www.fda.gov
Recall notice
Administration of an injectable product that contains particulate matter may result in local irritation or swelling. If the particulate matter reaches the blood vessels or is injected intravascularly it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. To date, Eugia US LLC has not received any reports of adverse events related to this recall.
Methocarbamol injection USP 1000 mg/10 mL (100mg/mL), is used as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is packaged in 10 mL and packed as 25 (vials) X 04 (Printed E-Flute cartons) X 01 (Shipper) with NDC code as 55150-223-10. Eugia US LLC shipped the entire lot to wholesalers nationwide from Jan 12, 2024, through Jan 16, 2024.
The product can be identified by product name on carton and vial label and with lot number 3MC23011 and Exp. Date: Nov 2026 (NDC 55150-223-10) (See enclosed vial label). The product label is as shown in the image below.
Eugia US LLC (f/k/a AuroMedics Pharma LLC) is notifying its distributors by recall letters and is arranging for the return/replacement of all recalled products. Wholesalers, hospitals, pharmacies, institutions, and doctors with an existing inventory of the recalled product lot should discontinue use, stop distribution and quarantine the product immediately. If you have further distributed the recalled product lot, notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
If you are experiencing any harm after using this product it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist seek medical attention.
Company name: Eugia US LLC
Brand name: Eugia US LLC
Product recalled: Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial)
Reason of the recall: Device & Drug Safety – Presence of Particulate Matter
FDA Recall date: March 28, 2024
Source: www.fda.gov
A scam mystery box Amazonbox, Colorado, USA
1 day ago •reported by user-hvffh693
I received a package I didn't order AND I received an email invoice for a computer software I can't find charges for (which account?) $300.00! Also, I tried to call customer service number on invoice and it was disconnected